Company Filing History:
Years Active: 2025
Title: Thomas Andersson: Innovator in Pharmaceutical Compositions
Introduction
Thomas Andersson is a notable inventor based in Segeltorp, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative approaches to drug compositions.
Latest Patents
Andersson holds a patent for pharmaceutical compositions comprising nilotinib. This patent discloses a composition that includes an amorphous solid dispersion (ASD) of nilotinib, along with at least one polymeric stabilizing and matrix-forming component. Additionally, it incorporates at least one solid organic acid mixed with the ASD, aimed at treating proliferative disorders.
Career Highlights
Thomas Andersson is associated with Xspray Pharma AB, a company focused on developing innovative pharmaceutical solutions. His work has been instrumental in advancing the understanding and application of nilotinib in medical treatments.
Collaborations
Andersson collaborates with various professionals in the pharmaceutical industry, including his coworker Andreas Fischer. Their combined expertise contributes to the ongoing development of effective pharmaceutical compositions.
Conclusion
Thomas Andersson's contributions to pharmaceutical innovations, particularly through his patent on nilotinib compositions, highlight his role as a key inventor in the field. His work continues to influence the treatment of proliferative disorders, showcasing the importance of innovation in healthcare.